Comments on the 2013 ESC/EASD guidelines on diabetes, prediabetes and cardiovascular diseases

被引:0
|
作者
Motz, W. [1 ]
Kerner, W. [1 ]
Doerr, R. [2 ]
机构
[1] Klinikum Karlsburg, Klin Grp Dr Guth GmbH & Co KG, Herz & Diabeteszentrum Mecklenburg Vorpommern, D-17495 Karlsburg, Germany
[2] Praxisklin Herz & Gefasse, Dresden, Germany
关键词
Diabetes mellitus type 2; Coronary artery disease; Blood pressure monitoring; Percutaneous coronary intervention; Coronary artery bypass surgery; ACUTE MYOCARDIAL-INFARCTION; ATRIAL-FIBRILLATION; ESC GUIDELINES; MORTALITY; MANAGEMENT; MELLITUS; INSULIN;
D O I
10.1007/s00059-014-4168-0
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Patients with type 2 diabetes mellitus have an increased cardiovascular risk compared with non-diabetics. The new guidelines provide physicians with orientation with respect to disorders in glucose metabolism and the risk of occurrence of cardiovascular diseases. An HBA1c level in the range of 6-8% is currently recommended, depending on cardiovascular comorbidities: in young diabetics 6% is recommended to avoid hypoglycemia and in older individuals with cardiovascular complications 8%. The target blood pressure given in the new guidelines is < 140/85 mmHg. The guidelines still recommend bypass surgery instead of percutaneous coronary intervention (PCI) for diabetics; however, this recommendation is based on studies that do not reflect current practice and is disputable. Diagnostic measures and therapy of cardiac failure and arrhythmic disorders in the guidelines do not essentially differ between patients with and without diabetes, basically due to a lack of studies.
引用
收藏
页码:971 / 982
页数:12
相关论文
共 50 条
  • [31] The Munich Myocardial Infarction Registry Translating the European Society of Cardiology (ESC) and European Association for the Study of Diabetes (EASD) guidelines on diabetes, prediabetes, and cardiovascular disease into clinical practice
    Schnell, Oliver
    Otter, Wolfgang
    Standl, Eberhard
    DIABETES CARE, 2009, 32 : S326 - S330
  • [32] Clinical Practice Guides ESC 2019 guide on diabetes, prediabetes and cardiovascular disease, in collaboration with the European Association for the Study of Diabetes (EASD)
    Cosentino, Francesco
    Grant, Peter J.
    Aboyans, Victor
    Bailey, Clifford J.
    Ceriello, Antonio
    Delgado, Victoria
    Federici, Massimo
    Filippatos, Gerasimos
    Grobbee, Diederick E.
    Hansen, Tina Birgitte
    Huikuri, Heikki, V
    Johansson, Isabelle
    Juni, Peter
    Lettino, Maddalena
    Marx, Nikolaus
    Mellbin, Linda G.
    Ostgren, Carl J.
    Rocca, Bianca
    Roffi, Marco
    Sattar, Naveed
    Seferovic, Petar M.
    Sousa-Uva, Miguel
    Valensi, Paul
    Wheeler, David C.
    REVISTA ESPANOLA DE CARDIOLOGIA, 2020, 73 (05):
  • [33] Comments on Guidelines on diabetes, pre-diabetes, and cardiovascular diseases
    Alexandrov, An. A.
    RATIONAL PHARMACOTHERAPY IN CARDIOLOGY, 2007, 3 (04) : 100 - 103
  • [34] Diabetes, pre-diabetes and cardiovascular diseases in light of the 2019 ESC Guidelines
    Zandecki, Lukasz
    Janion-Sadowska, Agnieszka
    Kurzawski, Jacek
    Janion, Marianna
    MEDICAL STUDIES-STUDIA MEDYCZNE, 2020, 36 (02) : 148 - 155
  • [35] 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD. Summary of the document prepared by the Czech Society of Cardiology
    Taborsky, Milos
    Linhart, Ales
    Rosolova, Hana
    Spinar, Jindrich
    COR ET VASA, 2020, 62 (02) : 105 - 138
  • [36] Erratum zu: Kommentar zu den Leitlinien (2019) der European Society of Cardiology (ESC) zu „Diabetes, Prädiabetes und kardiovaskuläre Erkrankungen“Erratum to: Comments on the ESC guidelines (2019) on diabetes, prediabetes and cardiovascular diseases
    N. Marx
    S. Frantz
    A. K. Gitt
    A. Zirlik
    Der Kardiologe, 2020, 14 (6): : 492 - 493
  • [37] ESC/EASD guideline sheds light on diabetes and cardiovascular disease management
    Chaplin, Steve
    PRACTICAL DIABETES, 2020, 37 (01) : 24 - 26
  • [38] Comments on the Guidelines (2017) of the ESC on peripheral arterial Diseases
    Espinola-Klein, C.
    Dahm, J. B.
    Heiss, C.
    Zahn, R.
    Tiefenbacher, C.
    KARDIOLOGE, 2018, 12 (04): : 241 - 249
  • [39] Cardiovascular Risk Categories in Patients with Diabetes According to 2019 ESC/EASD Guidelines in Clinical Practice: Use of a Dedicated App (AWARE)
    Berra, Cesare C.
    Manfrini, Roberto
    Ghelardi, Renata
    Bollati, Paola M.
    Bucciarelli, Loredana
    Mirani, Marco
    Muratori, Milena
    Folli, Franco
    DIABETES, 2021, 70
  • [40] ESC Guidelines on the management of cardiovascular diseases during pregnancy
    Regitz-Zagrosek, Vera
    Lundqvist, Carina Blomstrom
    Borghi, Claudio
    Cifkova, Renata
    Ferreira, Rafael
    Foidart, Jean-Michel
    Gibbs, J. Simon R.
    Gohlke-Baerwolf, Christa
    Gorenek, Bulent
    Iung, Bernard
    Kirby, Mike
    Maas, Angela H. E. M.
    Morais, Joao
    Nihoyannopoulos, Petros
    Pieper, Petronella G.
    Presbitero, Patrizia
    Roos-Hesselink, Jolien W.
    Schaufelberger, Maria
    Seeland, Ute
    Torracca, Lucia
    Bax, Jeroen
    Auricchio, Angelo
    Baumgartner, Helmut
    Ceconi, Claudio
    Dean, Veronica
    Deaton, Christi
    Fagard, Robert
    Funck-Brentano, Christian
    Hasdai, David
    Hoes, Arno
    Knuuti, Juhani
    Kolh, Philippe
    McDonagh, Theresa
    Moulin, Cyril
    Poldermans, Don
    Popescu, Bogdan A.
    Reiner, Zeljko
    Sechtem, Udo
    Sirnes, Per Anton
    Torbicki, Adam
    Vahanian, Alec
    Windecker, Stephan
    Baumgartner, Helmut
    Deaton, Christi
    Aguiar, Carlos
    Al-Attar, Nawwar
    Garcia, Angeles Alonso
    Antoniou, Anna
    Coman, Ioan
    Elkayam, Uri
    TURK KARDIYOLOJI DERNEGI ARSIVI-ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGY, 2012, 40 : 70 - 120